What Happened? Shares of medical device company Integra LifeSciences (NASDAQ:IART) fell 10.1% in the afternoon session after the company reported a second-qu...
Integra LifeSciences (NASDAQ:IART) reported second-quarter 2026 revenue of $419 million, up 0.8% on a reported basis and 0.7% organically from a year earlier, as improving supply reliability and operational execution supported results. Adjusted earnings per share rose 24% year over year to $0.56, ex
Medical device company Integra LifeSciences (NASDAQ:IART) met Wall Street’s revenue expectations in Q2 CY2026, but sales were flat year on year at $418.8 mil...
Medical device company Integra LifeSciences (NASDAQ:IART) will be announcing earnings results this Wednesday morning. Here’s what to look for. Integra LifeSc...
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as...
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
What Happened? Shares of medical device company Integra LifeSciences (NASDAQ:IART) jumped 4.3% in the afternoon session after BMO Capital initiated coverage ...
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...
Over the past six months, Integra LifeSciences has been a great trade, beating the S&P 500 by 25.3%. Its stock price has climbed to $17.91, representing a he...
What Happened? Shares of medical device company Integra LifeSciences (NASDAQ:IART) jumped 6.1% in the afternoon session after Citigroup upgraded its rating o...
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, u...
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However...
Integra LifeSciences (NASDAQ:IART) is keeping its core strategy intact following a leadership change that returned Stuart to the roles of chairman and chief executive officer, Chief Financial Officer Lea Knight said during a Bank of America med tech conference discussion hosted by analyst Rei Tan.
Integra LifeSciences delivered a first quarter that surpassed Wall Street expectations, as reflected by a significant positive market reaction. Management at...
What Happened? Shares of medical device company Integra LifeSciences (NASDAQ:IART) jumped 5.3% in the afternoon session after the company reported strong fir...
Medical device company Integra LifeSciences (NASDAQ:IART) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 2.4% year on year to $391.9 mil...
Medical device company Integra LifeSciences (NASDAQ:IART) will be reporting earnings this Tuesday before the bell. Here’s what to expect. Integra LifeScience...
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t...
Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them...
What a brutal six months it’s been for Integra LifeSciences. The stock has dropped 28.1% and now trades at $10.84, rattling many shareholders. This might hav...
